🇺🇸 FDA
Pipeline program

Buprenorphine (Subutex)

BU0902

Approved small_molecule completed

Quick answer

Buprenorphine (Subutex) for Opioid Dependency is a Approved program (small_molecule) at Indivior Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Indivior Pharmaceuticals
Indication
Opioid Dependency
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials